Penn Surgeons: Hep C Drugs Make More Kidneys Safe for Transplant

David Greenberg and Peter Reese of the Perelman School of Medicine are highlighted for conducting a pilot study of patients receiving a new Hepatitis C drug.

・ From Philadelphia Inquirer